A state-local partnership approach to Health in All Policies
This presentation will include a description of five key elements of HiAP that have been essential to the success of California’s Task Force. The presenter will review specific strategies to bring health and equity into the work of non-health state agencies. Focusing on identifying co-benefits and windows of opportunity, the presenter will describe in detail the process, challenges, and lessons learned from embedding health and equity in affordable housing and active transportation grant programs, land-use planning guidelines, and broad departmental and cross-agency policy documents, mission statements, and strategic plans. The presenter will describe the interaction between state, regional, and local governments around HiAP, and how efforts at the state level can support implementation of a HiAP approach to planning and policy development in local communities.
Learning Areas:Public health or related public policy
Public health or related research
List five key elements of Health in All Policies Identify at least three opportunities for embedding health and equity into government policies, programs, or strategies Describe how coordination between state, regional, and local Health in All Policies initiatives can promote, advance, and accelerate the adoption of a Health in All Policies approach across a wide geographic area
Keyword(s): Built Environment, Public Policy
Qualified on the content I am responsible for because: I have served as the Policy Associate for the California Health in All Policies Task Force for the last five years. I am a co-author of âHealth in All Policies: A Guide for State and Local Governments.â I have presented locally and nationally about this work as a subject matter expert, in addition to developing and presenting educational workshops on Health in All Policies.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.